0001209191-19-021091.txt : 20190322
0001209191-19-021091.hdr.sgml : 20190322
20190322194121
ACCESSION NUMBER: 0001209191-19-021091
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190206
FILED AS OF DATE: 20190322
DATE AS OF CHANGE: 20190322
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cohen Fred E
CENTRAL INDEX KEY: 0001339358
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38079
FILM NUMBER: 19701116
MAIL ADDRESS:
STREET 1: 301 COMMERCE STREET
STREET 2: SUITE 3300
CITY: FORT WORTH
STATE: TX
ZIP: 76102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UroGen Pharma Ltd.
CENTRAL INDEX KEY: 0001668243
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
BUSINESS PHONE: 972 9 770 7601
MAIL ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-06
0
0001668243
UroGen Pharma Ltd.
URGN
0001339358
Cohen Fred E
C/O UROGEN PHARMA LTD.
9 HA?TA?ASIYA STREET
RA?ANANA
L3
4365007
ISRAEL
1
0
0
0
Ordinary Shares
2019-02-06
4
M
0
15000
16.99
A
15000
D
Stock Option (Right to Buy)
16.99
2019-02-06
4
M
0
15000
0.00
D
2027-05-15
Ordinary Shares
15000
25000
D
6.25% of the ordinary shares underlying the stock option vested on each of August 15, 2017, November 15, 2017 and February 15, 2018; 31.25% of the shares vested on May 15, 2018, and the remaining shares vest in 8 equal quarterly installments thereafter.
/s/ Peter Pfreundschuh, Attorney-in-Fact
2019-03-20